Advanced company searchLink opens in new window

COVANCE CRS ANALYTICS LIMITED

Company number 02801202

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Dec 2023 GAZ2(A) Final Gazette dissolved via voluntary strike-off
10 Oct 2023 GAZ1(A) First Gazette notice for voluntary strike-off
28 Sep 2023 DS01 Application to strike the company off the register
04 Jul 2023 TM01 Termination of appointment of Robert Stewart Pringle as a director on 30 June 2023
04 Jul 2023 AP01 Appointment of Thomas Kremer as a director on 30 June 2023
02 Jun 2023 CS01 Confirmation statement made on 20 May 2023 with updates
02 Jun 2023 PSC05 Change of details for Covance Laboratories Limited as a person with significant control on 25 June 2021
06 Sep 2022 AA Accounts for a dormant company made up to 31 December 2021
25 May 2022 CS01 Confirmation statement made on 20 May 2022 with no updates
19 Apr 2022 AA Full accounts made up to 31 December 2020
12 Apr 2022 TM01 Termination of appointment of Stephen Derek Albert Street as a director on 11 April 2022
24 Mar 2022 DISS40 Compulsory strike-off action has been discontinued
08 Mar 2022 GAZ1 First Gazette notice for compulsory strike-off
09 Sep 2021 SH19 Statement of capital on 9 September 2021
  • GBP 1.01
27 May 2021 CS01 Confirmation statement made on 20 May 2021 with updates
16 Feb 2021 PSC02 Notification of Covance Laboratories Limited as a person with significant control on 24 December 2020
19 Jan 2021 PSC07 Cessation of Covance Crs Limited as a person with significant control on 24 December 2020
05 Jan 2021 AA Full accounts made up to 31 December 2019
22 Dec 2020 SH20 Statement by Directors
22 Dec 2020 CAP-SS Solvency Statement dated 11/12/20
22 Dec 2020 RESOLUTIONS Resolutions
  • RES13 ‐ Share premium account of the company to be cancelled in its entirety 11/12/2020
  • RES06 ‐ Resolution of reduction in issued share capital
15 Jun 2020 RP04SH01 Second filing of a statement of capital following an allotment of shares on 30 May 2019
  • GBP 101
20 May 2020 CS01 Confirmation statement made on 20 May 2020 with updates
20 May 2020 PSC07 Cessation of Pathfinder Clinical Development Limited as a person with significant control on 4 June 2019
20 May 2020 PSC02 Notification of Covance Crs Limited as a person with significant control on 4 June 2019